The "Traditional Chinese Medicine + Brain-Computer Interface" concept stock, BrainStorm Cell Therapeutics, which has attracted attention for several consecutive days, fell by 18.78% on Wednesday, with ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the ...

General Mills announced plans to eliminate all artificial colors from its U.S. foods by 2027, with the removal of synthetic dyes from cereals and foods served in schools set to take effect by the ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo® ...

CSL Behring’s Andembry is now approved as a subcutaneous, self-injection for hereditary angioedema (HAE) patients ages 12 and older and will be available by the end of June 2025.

Kraft Heinz and General Mills announce plans to eliminate controversial food dyes from all U.S. products by 2027 amid growing ...